{"id":147292,"date":"2023-05-25T07:31:57","date_gmt":"2023-05-25T11:31:57","guid":{"rendered":"https:\/\/44.250.171.167\/?p=147292"},"modified":"2023-05-25T07:31:58","modified_gmt":"2023-05-25T11:31:58","slug":"earnings-divis-laboratories-ltd-nse-divislab-q4fy23-results-out-total-income-fell-21-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-divis-laboratories-ltd-nse-divislab-q4fy23-results-out-total-income-fell-21-yoy\/","title":{"rendered":"Earnings | Divis Laboratories Ltd (NSE: DIVISLAB): Q4FY23 Results Out; Total Income fell 21% YoY."},"content":{"rendered":"\n<p>Divis Laboratories Ltd is a renowned Indian company specializing in the production and global export of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical ingredients. With a solid reputation in the pharmaceutical industry, the company has established itself as a leading manufacturer of high-quality chemicals. Divis Laboratories focuses on research, development, and manufacturing processes, adhering to strict quality standards to meet global regulatory requirements. Its API portfolio spans various therapeutic categories, serving the pharmaceutical industry&#8217;s diverse needs. In addition, the company also offers a range of intermediates and nutraceutical ingredients. Divis Laboratories&#8217; commitment to excellence and its robust product portfolio contribute to its position as a trusted and reliable supplier in the global market.<br>\u2022 Divis Laboratories Ltd reported Total Income for Q4 FY23 of \u20b92,017 Crore down from \u20b92,571 Crore year on year, a negative growth of 21%.<br>\u2022 Total Expenses for Q4 FY23 of \u20b91,550 Crore up from \u20b91,495 Crore year on year, a growth of 3%.<br>\u2022 Consolidated Net Profit of \u20b9 321 Crore, down 64% from \u20b9894 Crore in the same quarter of the previous year.<br>\u2022 The Earnings per Share is \u20b912.09, down 64% from \u20b933.70 in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"527\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4-1024x527.png\" alt=\"\" class=\"wp-image-147293\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4-1024x527.png 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4-300x154.png 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4-768x395.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4-1536x790.png 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4-2048x1053.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Divis Laboratories Ltd is a renowned Indian company specializing in the production and global export of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical ingredients. With a solid reputation in the pharmaceutical industry, the company has established itself as a leading manufacturer of high-quality chemicals. Divis Laboratories focuses on research, development, and manufacturing processes, adhering to [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-147292","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":168415,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy25-23-rise-in-profits\/","url_meta":{"origin":147292,"position":0},"title":"Divis Laboratories Ltd Q4FY25; 23% rise in Profits","author":"Divyansh_Kasana","date":"May 19, 2025","format":false,"excerpt":"\u00a0 Company Overview: Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients. Financial Results: Divis Laboratories reported Total revenue for Q4FY25 of \u20b9 2,671 Crore up from \u20b92,382 Crore in Q4FY24, a rise of 12% y-o-y. Total Expense for Q4FY25 of \u20b91,807 Crore up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172285,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-q2-fy26-earnings-results\/","url_meta":{"origin":147292,"position":1},"title":"Divis Laboratories Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 10, 2025","format":false,"excerpt":"Divis Laboratories Ltd, a leading manufacturer and exporter of APIs, intermediates, and nutraceutical ingredients, reported strong financial results for Q2FY26. Financial Highlights: Revenues increased 16.12% year on year to \u20b92,715 crore from \u20b92,338 crore. Total expenses went up 13.12% to \u20b91,948 crore from \u20b91,722 crore. Consolidated net profit surged 35.1%\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166064,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q2fy25-47-rise-in-profits\/","url_meta":{"origin":147292,"position":2},"title":"Divis Laboratories Ltd Q2FY25; 47% rise in Profits","author":"Divyansh_Kasana","date":"December 16, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q2FY25 of \u20b92,338.00 Crores up from \u20b91,909.00 Crore year on year, a rise of 22.47%. Total Expenses for Q2FY25 of \u20b91,722.00 Crores up from \u20b91,526.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164227,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q1fy25-21-rise-in-profits\/","url_meta":{"origin":147292,"position":3},"title":"Divis Laboratories Ltd Q1FY25; 21% rise in Profits","author":"Divyansh_Kasana","date":"September 4, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q1FY25 of \u20b92,118.00 Crores up from \u20b91,778.00 Crore year on year, a rise of 19.12%. Total Expenses for Q1FY25 of \u20b91,593.00 Crores up from \u20b91,367.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169024,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy25-23-rise-in-profits-2\/","url_meta":{"origin":147292,"position":4},"title":"Divis Laboratories Ltd Q4FY25; 23% rise in Profits","author":"Divyansh_Kasana","date":"July 7, 2025","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q4FY25 of \u20b92,585.00 Crores up from \u20b92,303.00 Crore year on year, a rise of 12.24%. Total Expenses for Q4FY25 of \u20b91,807.00 Crores up from \u20b91,669.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167573,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q3fy25-65-rise-in-profits\/","url_meta":{"origin":147292,"position":5},"title":"Divis Laboratories Ltd Q3FY25; 65% rise in Profits","author":"Divyansh_Kasana","date":"March 26, 2025","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q3FY25 of \u20b92,319.00 Crores up from \u20b91,855.00 Crore year on year, a rise of 25.01%. Total Expenses for Q3FY25 of \u20b91,675.00 Crores up from \u20b91,461.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=147292"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147292\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=147292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=147292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=147292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}